Financial statements Mk Pharm
Balance sheet data of MK PHARM
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 5 702 968,71 | 5 770 466,27 | 6 085 493,59 | 7 087 448,18 | 7 230 633,33 | 8 024 666,54 |
A. Fixed assets | 471 655,43 | 740 690,47 | 865 555,21 | 788 372,14 | 831 096,02 | 134 943,07 |
B. Current assets | 5 231 313,28 | 5 029 775,80 | 5 219 938,38 | 6 299 076,04 | 6 399 537,31 | 7 889 723,47 |
C. Share capital contributions (basic funds) | - | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - | - |
Total liabilities | 5 702 968,71 | 5 770 466,27 | 6 085 493,59 | 7 087 448,18 | 7 230 633,33 | 8 024 666,54 |
A. Equity | 966 697,60 | 1 105 929,33 | 1 282 804,15 | 2 345 107,55 | 2 525 794,65 | 2 560 869,57 |
B. Liabilities and provisions for liabilities | 4 736 271,11 | 4 664 536,94 | 4 802 689,44 | 4 742 340,63 | 4 704 838,68 | 5 463 796,97 |
I. Long-term liabilities | 0,00 | 0,00 | 1 594 025,00 | 232 462,05 | 0,00 | - |
II. Short-term liabilities | 4 708 572,64 | 4 641 781,30 | 3 174 539,40 | 4 462 574,13 | 4 670 224,90 | 5 418 774,65 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.